Proteolysis of insulin-like growth factor-binding protein-3 in the male reproductive tract

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 618-624

  Plymate, Stephen R ^a,b   Rosen, Clifford J ^c   Paulsen, C Alvin ^b   Ware, Joy L ^d   Chen, Juza ^d,e   Vessella, Robert E ^b   Birnbaum, Roger S ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c ST JOSEPH HOSPITAL   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; CAUCASIAN; HUMAN; MALE; MALE GENITAL SYSTEM; NEGRO; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN DEGRADATION; SEMINAL PLASMA; SPERMATOZOON COUNT;

BLOTTING, WESTERN; ENDOPEPTIDASES; HUMANS; IMMUNOBLOTTING; IMMUNORADIOMETRIC ASSAY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; SEMEN;

EID: 0030062660     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.618     Document Type: Article

References (37)

1. Cohen P, Peehl D, Lamson G, Rosenfeld R. 1991 Insulin-like growth factors (IGFs) IGF receptor, and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab. 73:401-407.
2. Iwamura M, Sluss P, Casamento J, Cockett A. 1993 Insulin-like growth factor I: action, and receptor characterization in human prostate cancer cell lines. Prostate. 22:243-252.
3. Pietrzkowski Z, Mulholland G, Gomella L, Jameson B, Wernicke D, Baserga R. 1993 Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Cancer Res. 531:1102-1106.
4. Lee K-O, Oh Y, Guidice L, Cohen P, Peehl D, Rosenfeld R. 1994 Identification of Insulin-like growth factor binding protein-3 (IGFBP-3) fragments and IGFBP-5 proteolytic activity in human seminal plasma: a comparison of normal and vasectomized patients. J Clin Endocrinol Metab. 79:1367-1372.
5. Barni T, Vannelli B, Sadri R, et al. 1994 Insulin-like growth factor-I (IGF-I) and its binding protein IGFBP-4 in human prostatic hyperplastic tissue: gene expression and its cellular localization. J Clin Endocrinol Metab. 78:778-783.
6. Fiorelli G, de Bellis A, Longo A, et al. 1991 Insulin-like growth factor-I receptor in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J Clin Endocrinol Metab. 72:740-746.
7. Kaicer E, Blat C, Imbenotte J, et al. 1993 IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth. Growth Regul. 3:180-189.
8. Plymate S, Thrasher J, Ware J, Drivdahl R, Birnbaum R. Insulin-like growth factor binding proteins (IGFBP) differentially affect the action of insulin-like growth factors (IGF)-I and -II on human prostate epithelial cells (PEC) [Abstract]. Proc of the 76th Annual Meet of The Endocrine Soc. 1994; 549.
9. Birnbaum R, Ware J, Plymate S. 1994 Insulin-like growth factor-binding protein-3 expression and secretion by cultures of human prostate epithelial cells and stromal fibroblasts. J Endocrinol. 141:535-540.
10. Plymate S, Ware J, Thrasher J, Birnbaum R. Insulin-like growth factor binding protein secretion differs in normal, and neoplastic prostate [Abstract]. Proc of the 75th Annual Meet of The Endocrine Soc. 1993; 126.
11. Andress D, Birnbaum R. 1992 Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem. 267:22467-22472.
12. Clemmons D, Jones J, Busby W, Wright G. 1993 Role of insulin-like growth factor binding proteins in modifying IGF actions. Ann NY Acad Sci. 692:10-21.
13. Jones J, Busby Jr W, Wright G, Smith C, Kimack N, Clemmons D. 1993 Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. J Biol Chem. 268:1125-1131.
14. Blum W, Jenne E, Reppin F, Kietzmann K, Ranke M, Bierich J. 1989 Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology. 125:766-772.
15. Kratz G, Lake M, Ljungström K, Forsberg G, Hoegerstrand A, Gidlund M. 1992 Effect of recombinant IGF binding protein-1 on primary cultures of human keratinocytes and fibroblast: selective enhancement of IGF-1 but not IGF-2-induced cell proliferation. Exp Cell Res. 202:381-385.
16. Oh Y, Müller H, Lamson G, RG R. 1993 Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem. 268:14964-14971.
17. Koutsilieris M, Frenette G, Lazure C, Lehoux J, Govindan M, Polychronakos C. 1993 Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases. Anticancer Res. 13:481-486.
18. Cohen P, Graves H, Peehl D, Kamarei M, Giudice L, Rosenfeld R. 1992 Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab. 75:1046-1053.
19. Tennant M, Twomey P, Thrasher J, Birnbaum R, Plymate S. Comparison of insulin-like growth factor-binding protein-2 and -3 mRNA and protein in normal human prostate epithelium, prostate intraepithelial neoplasia, and malignant tissue. J Clin Endocrinol Metab. In press.
20. Marcelli M, Haidacher S, Plymate S, Birnbaum R. 1995 Altered growth and insulin-like growth factor-binding protein-3 production in PC-3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid. Endocrinology. 136:1040-1048.
21. Nagao R, Plymate S, Berger R, Perrin E, Paulsen C. 1986 Comparison of gonadal function between fertile and infertile men with varicoceles. Fertil Steril. 46:930-933.
22. Birnbaum R, Wiren K. 1994 Changes in insulin-like growth factor-binding protein expression and secretion during the proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts. Endocrinology. 135:223-230.
23. Powell D, Liu F, Baker B, et al. 1993 Characterization of insulin-like growth factor binding protein -3 in chronic renal failure serum. Pediatr Res. 33:136-143.
24. Takayama T, Vessella R, Brawer M, True L, Noteboom J, Lange P. 1994 Urinary prostate specific antigen levels after radical prostatectomy. J Urol. 151:82-87.
25. Vessella R, Noteboom J, Lange P. 1992 Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen. Clin Chem. 38:2044-2045.
26. Koistinen H, Seppälä M, Koistinen R. 1994 Different forms of insulin-like growth factor-binding protein-3 detected in serum and seminal plasma by immunofluorometric assay with monoclonal antibodies. Clin Chem. 40:531-536.
27. Ovensen P, Flyvbjerg A, Ørskov H. 1995 Insulin-like growth factor 1 (IGF-I), and IGF binding proteins in seminal plasma before and after vasectomy in normal men. Fertil Steril. 63:913-918.
28. Jones J, Clemmons D. 1995 Insulin-like growth factors, and their binding proteins: biological actions. Endocr Rev. 16:3-34.
29. Mawhinney M. 1983 Male accessory sex organs and androgen action in infertility in the male. In: Lipshultz LI, Howards SS, eds. The male. New York: Churchill Livingston; 135-164.
30. Hsing A, Devesa S. 1994 Prostate cancer in the United States by cohort year of birth: 1865-1940. Cancer Epidemiol Biomarkers Prev. 3:527-530.
31. Pienta K, Demers R, Hoff M, Kau T, Montie J, Severson R. 1995 Effect of age and race on the survival of men with prostate cancer in the metropolitan Detroit tricounty area. Urology. 45:93-101.
32. Demers R, Swanson G, Weiss L, Kau T. 1994 Increasing incidence of cancer of the prostate. The experience of black and white men in the Detroit metropolitan area. Arch Intern Med. 154:1211-1216.
33. Morton R. 1994 Racial differences in adenocarcinoma of the prostate in North American men. Urology. 44:637-645.
34. Brawn P, Johnson E, Kuhl D, et al. 1993 Stage at presentation and survival of black patients with prostate carcinoma. Cancer. 1993:2569-2573.
35. Clemmons D. 1993 IGF binding proteins and their functions. Mol Reprod Dev. 35:368-374.
36. Armbruster D. 1993 Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin Chem. 39:181-195.
37. Conover C, Perry J, Tindall D. 1995 Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. J Clin Endocrinol Metab. 80:987-993.